bioskin joins Eurofins Scientific
bioskin joins Eurofins Scientific
In line with our strategy to expand our global leadership in cosmetics and personal care and to diversify our clinical testing footprint in dermatology, for medicinal products and medical devices, Eurofins announces that it has successfully completed acquisition of bioskin GmbH (“bioskin”) a full-service, dermatology-specific CRO specialising in trials for drugs, medical devices, food supplements and advanced cosmetics.
This acquisition, providing a range of complementary and extended services, supports Eurofins’ continued growth plans in these markets and further strengthens our offering to our customers and facilitates their one-stop access to multicentric studies.
Yann Agustin, Managing Director Cosmetics & Personal Care Product Testing Europe, commented, “We are pleased to welcome on board bioskin’s team. This acquisition will expand our capabilities in Germany and will even further strengthen our expertise in the field of clinical study management in particular in dermatology drugs and medical devices, adding highly recognised scientists to our network.”
Dr. Walter Wigger-Alberti, CEO of bioskin, said, “We very much appreciate being a part of Eurofins, and we look forward to fruitful cooperation and the exchange of great expertise between us and the valuable worldwide testing institutes that are part of Eurofins.”
About bioskin
|
|
Over the last 30 years bioskin has built a reputation for excellence in providing clinical trials in dermatology for medicinal products and for medical devices. bioskin has innovative capabilities, a strong position in early phase studies and proof-of-concept models, international multi-centre phase II–III studies, and unique expertise with its own in-house research centre. bioskin employs over 60 staff in its facility in Hamburg and has generated revenues of over EUR 11m in 2020. |
About Eurofins and its Cosmetics & Personal Care Business Line
Eurofins Cosmetics & Personal Care is the leading provider in cosmetics and personal care testing worldwide, offering the most comprehensive service portfolio from its state-of-the-art cosmetics testing laboratories across the globe. With a network of over 26 high-level laboratories active in the field across Europe, North America, Asia-Pacific and Africa, Eurofins Cosmetics & Personal Care offers an unmatched range of services to both top-tier international and local clients, including: regulatory and toxicological services, physico-chemical analyses, microbiology, ecotoxicity and biodegradability, in vitro testing, clinical studies, consumer tests and sensory evaluation, and audit and consulting services.
Eurofins Cosmetics & Personal Care is part of the Eurofins Group.
Eurofins is Testing for Life. Eurofins is the global leader in food, environment, and pharmaceutical product testing. It is also one of the market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing.
With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
